Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiming Sun

Showing results (281-290 of 283) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 283 results.
Nature Communications|June 10, 2023
Experimental demonstration of a skyrmion-enhanced strain-mediated physical reservoir computing systemYiming Sun, Tao Lin, Na Lei, et al.
Human Reproduction (Oxford, England)|May 26, 2021
Novel biallelic mutations in MEI1: expanding the phenotypic spectrum to human embryonic arrest and recurrent implantation failureJie Dong, Hong Zhang, Xiaoyan Mao, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaYingqiang Liu, Zhengsheng Zhan, Zhuang Kang, et al.
Pageof 29

Showing results (281-290 of 283) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 283 results.
Nature Communications|June 10, 2023
Experimental demonstration of a skyrmion-enhanced strain-mediated physical reservoir computing systemYiming Sun, Tao Lin, Na Lei, et al.
Human Reproduction (Oxford, England)|May 26, 2021
Novel biallelic mutations in MEI1: expanding the phenotypic spectrum to human embryonic arrest and recurrent implantation failureJie Dong, Hong Zhang, Xiaoyan Mao, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaYingqiang Liu, Zhengsheng Zhan, Zhuang Kang, et al.
Pageof 29